EU GMP Chapter 1 Pharmaceutical Quality SystemCritical 99 · Major 1,411 · Other 1,325
Paragraph
Critical
Major
Other
Total
Inspections
1.4(xiv)
15
225
215
455
368
1.8(vii)
10
150
107
267
230
1.4(viii)
10
116
101
227
194
1.4(xii)
5
94
85
184
171
1.4(xiii)
2
66
54
122
119
1.6
3
72
46
121
117
1.8(iv)
1
27
64
92
74
1.5
5
64
18
87
78
1.8(v)
1
29
53
83
66
1.8(iii)
3
22
43
68
62
1.4(vii)
3
26
36
65
63
1.12
2
43
17
62
61
1.10(i-xii)
0
26
33
59
58
1.4(xi)
2
35
18
55
50
1.13(i-ii)
1
40
13
54
51
Principle
6
25
21
52
49
1.4(vi)
3
13
35
51
50
1.8(xi)
3
40
7
50
50
1.3
1
25
23
49
41
1.4(ix)
2
29
15
46
45
1.9(iv)
2
15
29
46
41
1.10(i)
0
14
25
39
38
1.4(xvi)
0
10
25
35
32
1.8(ix)
0
6
26
32
30
1.4(xvii)
0
16
14
30
29
1.8(i)
3
7
19
29
26
1.4(iv)
0
11
16
27
26
1.11
0
10
17
27
27
1.4(i)
2
19
5
26
25
1.8(vi)
5
10
11
26
25
1.9(i)
0
9
16
25
25
1.13(i)
0
14
9
23
23
1.4(x)
1
6
6
13
12
1.4(xv)
0
8
5
13
12
1.10(vii)
0
5
8
13
13
1.13(ii)
0
9
4
13
13
1.1
2
6
4
12
12
1.2
0
1
9
10
10
1.8(x)
1
7
2
10
10
1.10(iv)
0
6
4
10
10
1.4(iii)
0
2
7
9
9
1.7
0
7
2
9
9
1.9(iii)
1
3
5
9
9
1.9(vi)
0
5
4
9
9
1.4(v)
0
6
2
8
7
1.8(ii)
0
4
4
8
7
1.8(viii)
0
4
3
7
7
1.4(ii)
0
4
2
6
6
1.10(ii)
0
1
5
6
6
1.10(viii)
0
0
6
6
6
1.10(xi)
0
2
4
6
6
1.10(vi)
0
0
5
5
5
1.10(xii)
0
2
3
5
5
1.4(i-xvii)
2
2
0
4
4
1.10(v)
0
1
3
4
4
1.4 (xiv)
0
3
0
3
2
1.9(i-viii)
1
1
1
3
3
1.9(v)
1
1
1
3
3
1.9(vii)
0
0
3
3
3
1.10(ix)
0
2
1
3
3
(whole chapter)
0
1
1
2
2
1.10(iii)
0
0
2
2
2
1.10(x)
0
1
1
2
2
1.4 (xii)
0
1
0
1
1
1.4 (xiiii)
0
1
0
1
1
1.5. C1.6
0
1
0
1
1
1.8(i-xi)
0
0
1
1
1
1.9(ii)
0
0
1
1
1
EU GMP Chapter 2 PersonnelCritical 14 · Major 143 · Other 264
Paragraph
Critical
Major
Other
Total
Inspections
2.11
2
26
111
139
130
2.1
6
36
22
64
56
2.10
0
15
41
56
51
2.4
5
14
5
24
22
2.3
0
7
10
17
17
2.12
0
8
9
17
17
Principle
0
6
11
17
16
2.9(i-xiii)
1
3
7
11
10
2.23
0
3
5
8
8
2.15
0
2
5
7
7
2.18
0
1
6
7
7
2.5
0
3
2
5
4
2.7(vi)
0
0
5
5
5
2.8(vii)
0
0
5
5
5
2.13
0
1
4
5
4
2.2
0
2
2
4
4
2.9(xiii)
0
4
0
4
4
2.8(i)
0
0
3
3
3
2.19
0
0
3
3
3
2.8(i-vii)
0
1
1
2
2
2.9(ii)
0
1
1
2
2
2.9(xii)
0
2
0
2
2
2.6(a)
0
1
0
1
1
2.6(a-b)
0
0
1
1
1
2.7
0
1
0
1
1
2.7(i)
0
0
1
1
1
2.8
0
1
0
1
1
2.8(ii)
0
0
1
1
1
2.9(i)
0
0
1
1
1
2.9(iii)
0
1
0
1
1
2.9(v)
0
1
0
1
1
2.9(vii)
0
1
0
1
1
2.9(x)
0
1
0
1
1
2.9(xi)
0
1
0
1
1
2.14
0
0
1
1
1
2.16
0
0
1
1
1
EU GMP Chapter 3 Premises and EquipmentCritical 16 · Major 279 · Other 699
Paragraph
Critical
Major
Other
Total
Inspections
3.34
3
25
71
99
87
3.19
0
16
82
98
87
3.41
0
13
83
96
90
3.2
3
23
55
81
75
3.36
1
18
43
62
52
3.6
3
34
22
59
55
3.3
0
20
37
57
53
Principle
0
17
26
43
38
3.18
0
9
24
33
30
3.1
1
15
14
30
29
3.38
1
4
25
30
30
3.37
1
10
17
28
25
3.8
1
11
15
27
27
3.4
0
3
21
24
24
3.9
1
9
14
24
24
3.23
0
1
17
18
18
3.27
0
4
14
18
12
3.14
1
6
10
17
17
3.39
0
5
12
17
17
3.5
0
1
13
14
13
3.35
0
4
10
14
13
3.7
0
10
3
13
13
3.42
0
0
12
12
12
3.12
0
2
8
10
10
3.22
0
0
10
10
10
3.40
0
0
10
10
10
3.44
0
3
7
10
10
3.21
0
2
4
6
6
3.15
0
5
0
5
5
3.43
0
2
3
5
5
3.10
0
1
3
4
4
3.20
0
1
3
4
4
3.25
0
1
3
4
4
3.11
0
1
1
2
2
3.13
0
0
2
2
2
3.17
0
1
1
2
2
3.29
0
1
1
2
1
3.6(i-iii)
0
1
0
1
1
3.28
0
0
1
1
1
3.30
0
0
1
1
1
3.31
0
0
1
1
1
EU GMP Chapter 4 DocumentationCritical 17 · Major 346 · Other 1,097
Paragraph
Critical
Major
Other
Total
Inspections
4.8
5
52
187
244
185
4.3
1
47
161
209
148
4.1
1
51
147
199
155
4.2
1
39
122
162
135
Principle
3
45
91
139
115
4.5
0
15
98
113
103
4.4
0
13
39
52
48
4.29
0
8
33
41
35
4.9
1
11
27
39
38
4.10
2
13
24
39
37
4.31
1
4
27
32
30
4.7
0
7
13
20
20
4.6
0
6
11
17
17
4.27
1
4
7
12
12
4.30
0
0
11
11
11
4.18(d)
0
0
9
9
9
4.11
0
5
3
8
8
4.26
1
2
5
8
8
4.12
0
4
3
7
6
4.20(e)
0
1
6
7
7
4.20(c)
0
0
6
6
6
4.13
0
0
5
5
5
4.25
0
3
2
5
5
4.32
0
1
4
5
5
4.18(a-g)
0
0
4
4
4
4.19(h)
0
0
4
4
4
4.20(a-i)
0
0
4
4
4
4.20(f)
0
1
3
4
4
4.19(a-i)
0
0
3
3
3
4.20(b)
0
1
2
3
3
4.21(g)
0
1
2
3
3
4.14(A)
0
1
1
2
2
4.14(a-e)
0
0
2
2
2
4.14(c)
0
0
2
2
2
4.18(b)
0
1
1
2
2
4.19(i)
0
0
2
2
2
4.20(h)
0
2
0
2
2
4.21(c)
0
0
2
2
2
4.21(d)
0
0
2
2
2
4.21(e)
0
0
2
2
2
4.21(f)
0
0
2
2
2
4.22
0
0
2
2
2
4.23
0
1
1
2
2
4.23(a-h)
0
1
1
2
1
4.24
0
1
1
2
2
(whole chapter)
0
0
1
1
1
4.14
0
1
0
1
1
4.14(b)
0
0
1
1
1
4.18(c )
0
0
1
1
1
4.18(f)
0
0
1
1
1
4.19(d)
0
0
1
1
1
4.19(e)
0
0
1
1
1
4.19(f)
0
0
1
1
1
4.19(g)
0
0
1
1
1
4.20(d)
0
1
0
1
1
4.20(g)
0
0
1
1
1
4.21(a-i)
0
0
1
1
1
4.21(h)
0
1
0
1
1
4.21(i)
0
0
1
1
1
4.23(f)
0
0
1
1
1
4.28
0
0
1
1
1
4.40(b)
0
1
0
1
1
4.40(f)
0
1
0
1
1
EU GMP Chapter 5 ProductionCritical 25 · Major 431 · Other 792
Paragraph
Critical
Major
Other
Total
Inspections
5.20
3
67
42
112
108
5.27
1
21
72
94
92
5.19
4
46
36
86
83
5.10
3
33
42
78
69
5.29
1
18
59
78
74
5.18
2
35
30
67
62
5.21(all)
3
43
14
60
60
5.7
0
5
36
41
37
5.13
1
7
33
41
36
5.30
0
3
37
40
40
5.2
0
3
26
29
29
5.50
0
4
23
27
27
5.49
0
6
20
26
26
5.12
0
3
22
25
25
5.21 Organisational Measures
0
11
14
25
24
5.22
2
10
11
23
23
5.28
1
10
11
22
22
5.3
0
4
16
20
19
5.23
1
11
7
19
18
5.45
0
3
15
18
18
5.46
0
4
14
18
18
5.43
0
3
14
17
17
5.57
0
2
15
17
17
5.9
0
10
6
16
16
5.40
0
5
11
16
16
5.66
0
3
13
16
16
5.26
0
9
6
15
15
5.8
0
2
10
12
12
5.52
0
2
9
11
10
5.21 Technical Measures
0
5
5
10
10
5.17
1
2
6
9
9
5.24
1
4
4
9
9
5.48
0
2
6
8
8
5.60
0
1
7
8
8
5.61
0
1
7
8
8
5.15
0
2
5
7
7
5.25
1
2
4
7
7
5.4
0
1
5
6
6
5.11
0
1
5
6
6
5.38
0
2
4
6
6
5.59(iii)
0
1
5
6
6
Principle
0
0
6
6
6
5.5
0
1
4
5
5
5.33
0
0
5
5
5
5.32(i-iv)
0
2
2
4
4
5.41
0
0
4
4
4
5.42
0
3
1
4
4
5.54
0
2
2
4
4
5.59(v)
0
0
4
4
4
5.67
0
1
3
4
4
5.32(iii)
0
1
2
3
3
5.34
0
0
3
3
3
5.36(ii)
0
1
2
3
3
5.53
0
0
3
3
3
5.59(i-v)
0
1
2
3
3
5.59(iv)
0
0
3
3
3
5.62
0
1
2
3
3
5.1
0
1
1
2
2
5.21
0
2
0
2
2
5.35
0
2
0
2
2
5.36(v)
0
1
1
2
2
5.39
0
1
1
2
2
5.55
0
1
1
2
2
5.56
0
0
2
2
2
5.70
0
1
1
2
2
5.71
0
1
1
2
2
5.14
0
0
1
1
1
5.16
0
0
1
1
1
5.32(ii)
0
0
1
1
1
5.36(i)
0
0
1
1
1
5.36(i-v)
0
0
1
1
1
5.37
0
0
1
1
1
5.44
0
0
1
1
1
5.58
0
0
1
1
1
5.59(i)
0
1
0
1
1
5.65
0
0
1
1
1
EU GMP Chapter 6 Quality ControlCritical 10 · Major 187 · Other 396
Paragraph
Critical
Major
Other
Total
Inspections
6.19
1
16
56
73
71
6.9
2
26
42
70
62
6.12
0
8
35
43
39
6.15
2
17
23
42
39
6.35
1
19
20
40
35
6.16
1
9
23
33
33
6.13
0
5
15
20
19
6.5
0
4
15
19
17
6.7(iv)
0
6
13
19
17
6.21
0
4
13
17
17
6.7(ii)
0
3
13
16
15
6.6
0
3
12
15
15
6.23
0
5
10
15
15
6.27
0
5
8
13
13
6.26
0
3
9
12
12
6.3
0
3
7
10
10
6.20
0
2
8
10
10
6.34
0
7
2
9
9
6.7(i-vii)
0
3
5
8
8
6.36
1
4
3
8
8
6.8
0
3
3
6
6
6.10
0
2
3
5
4
6.11(i-ix)
0
2
3
5
3
6.37
0
3
2
5
5
Principle
1
1
3
5
5
6.1
0
2
2
4
4
6.17(iv)
0
3
1
4
4
6.17(vii)
0
1
3
4
4
6.28
0
0
4
4
4
6.2
0
1
2
3
3
6.7(iii)
0
0
3
3
3
6.7(v)
0
0
3
3
3
6.7(vii)
0
2
1
3
3
6.11
0
1
2
3
3
6.11(iii)
0
0
3
3
3
6.17(vi)
0
1
2
3
3
6.22
0
0
3
3
3
6.29
0
1
2
3
3
6.33
0
1
2
3
3
6.38
0
2
1
3
3
6.7(i)
1
1
0
2
2
6.7(vi)
0
0
2
2
2
6.11(i)
0
0
2
2
2
6.17(i-ix)
0
2
0
2
2
6.17(ix)
0
0
2
2
2
6.17(viii)
0
1
1
2
2
6.24
0
1
1
2
2
6.32
0
1
1
2
2
6.39(i-v)
0
2
0
2
2
6.4
0
0
1
1
1
6.11(iv)
0
0
1
1
1
6.11(viii)
0
0
1
1
1
6.17(iii)
0
0
1
1
1
6.18
0
0
1
1
1
6.25
0
0
1
1
1
6.30(iii)
0
0
1
1
1
6.39(iii)
0
1
0
1
1
EU GMP Chapter 7 Outsourced ActivitiesCritical 1 · Major 116 · Other 354
Paragraph
Critical
Major
Other
Total
Inspections
7.1
0
18
63
81
79
7.15
0
18
60
78
75
7.14
0
12
54
66
62
7.5
0
14
32
46
46
7.7
1
14
28
43
41
7.4
0
10
31
41
41
Principle
0
6
28
34
34
7.8
0
9
16
25
25
7.6
0
2
8
10
10
7.11
0
1
8
9
9
7.2
0
4
4
8
8
7.17
0
1
7
8
8
7.16
0
2
5
7
7
7.9
0
2
4
6
6
7.10
0
1
3
4
4
7.12
0
1
3
4
4
7.3
0
1
0
1
1
EU GMP Chapter 8 Complaints and Product RecallCritical 4 · Major 210 · Other 316
Paragraph
Critical
Major
Other
Total
Inspections
8.30
0
28
68
96
96
8.15
1
12
17
30
30
8.18
0
14
14
28
27
8.10
0
14
12
26
26
8.13
1
14
11
26
26
8.29
0
10
16
26
26
Principle
0
11
13
24
23
8.16
1
12
9
22
21
8.6
0
3
15
18
18
8.11
0
9
9
18
18
8.20
1
5
12
18
18
8.22
0
6
12
18
18
8.9(iv)
0
6
9
15
15
8.5
0
5
9
14
14
8.9(ix)
0
7
7
14
13
8.26
0
5
8
13
13
8.12
0
8
4
12
12
8.19
0
3
8
11
11
8.14
0
5
3
8
8
8.9(i-ix)
0
3
4
7
7
8.9(iii)
0
3
4
7
7
8.23
0
2
5
7
7
8.25
0
3
4
7
7
8.9(ii)
0
1
5
6
6
8.9(viii)
0
3
3
6
6
8.17
0
3
3
6
6
8.21
0
2
4
6
6
8.1
0
2
3
5
5
8.9(v)
0
2
3
5
5
8.28
0
3
2
5
5
8.3
0
0
4
4
4
8.7
0
1
3
4
4
8.8
0
1
3
4
4
8.4
0
1
2
3
3
8.9(vi)
0
0
3
3
3
8.27
0
1
1
2
2
(whole chapter)
0
0
1
1
1
8.2
0
0
1
1
1
8.9(i)
0
1
0
1
1
8.9(vii)
0
1
0
1
1
8.31
0
0
1
1
1
8.34
0
0
1
1
1
EU GMP Chapter 9 Self InspectionCritical 0 · Major 21 · Other 50
Paragraph
Critical
Major
Other
Total
Inspections
9.1
0
10
22
32
32
Principle
0
5
10
15
15
9.2
0
4
9
13
13
9.3
0
2
9
11
11
EU GMP Annex 1 Manufacture of Sterile Medicinal ProductsCritical 62 · Major 430 · Other 285
Paragraph
Critical
Major
Other
Total
Inspections
64
4
46
34
84
78
18
7
29
18
54
52
20
6
21
18
45
43
46
3
15
10
28
28
67
0
13
14
27
26
8
2
13
9
24
24
37
3
10
11
24
23
61
1
13
10
24
24
81
0
17
4
21
21
43
0
9
11
20
20
54
2
8
8
18
17
22
1
12
4
17
17
9
2
9
5
16
16
47
1
11
4
16
16
73
3
11
2
16
16
42
0
10
5
15
14
24
1
7
6
14
13
41
1
8
5
14
14
3
1
9
3
13
13
19
3
6
3
12
12
Principle
1
8
3
12
12
11
0
3
8
11
11
44
1
2
8
11
11
85
1
7
2
10
10
124
0
2
8
10
10
53
1
7
1
9
9
83
0
7
2
9
9
127(a)
0
4
5
9
9
77
0
6
2
8
8
84
0
7
1
8
7
95
0
6
2
8
8
6
0
3
4
7
7
45
2
3
2
7
7
68
1
6
0
7
7
86
0
5
2
7
7
25
0
1
5
6
5
55
1
2
3
6
6
60
0
4
2
6
6
113
0
3
3
6
6
7
0
3
2
5
5
66
0
5
0
5
5
10
0
3
1
4
4
15
0
1
3
4
4
17
0
4
0
4
4
33
2
2
0
4
4
40
1
1
2
4
4
51
2
2
0
4
4
52
2
1
1
4
4
80
0
3
1
4
4
96
0
3
1
4
4
1
1
1
1
3
3
4
1
2
0
3
3
13
0
1
2
3
3
49
1
0
2
3
3
70
0
3
0
3
3
74
0
2
1
3
3
82
0
2
1
3
3
101
0
2
1
3
3
127(b)
0
0
3
3
3
30
0
0
2
2
2
32
0
1
1
2
2
36
0
2
0
2
2
57
0
2
0
2
2
59
0
0
2
2
2
62
1
1
0
2
2
69
0
1
1
2
2
76
0
2
0
2
2
78
0
2
0
2
2
90
0
1
1
2
2
111
0
1
1
2
2
117
0
2
0
2
2
121
0
0
2
2
2
125
0
2
0
2
2
(whole chapter)
0
0
1
1
1
12
0
1
0
1
1
21
1
0
0
1
1
23
0
1
0
1
1
27
0
1
0
1
1
29
0
0
1
1
1
31
0
1
0
1
1
48
0
1
0
1
1
58
1
0
0
1
1
72
0
0
1
1
1
79
0
0
1
1
1
87
0
1
0
1
1
94
0
0
1
1
1
98
0
0
1
1
1
99
0
1
0
1
1
114
0
1
0
1
1
122
0
1
0
1
1
EU GMP Annex 2 Biological Active Substances and Medicinal ProductsCritical 0 · Major 8 · Other 7
Paragraph
Critical
Major
Other
Total
Inspections
(whole chapter)
0
8
7
15
9
EU GMP Annex 3 RadiopharmaceuticalsCritical 0 · Major 5 · Other 5
Paragraph
Critical
Major
Other
Total
Inspections
25
0
1
1
2
2
6
0
1
0
1
1
7
0
1
0
1
1
10
0
0
1
1
1
26
0
0
1
1
1
31
0
1
0
1
1
34
0
0
1
1
1
41
0
0
1
1
1
44
0
1
0
1
1
EU GMP Annex 5 Immunological Veterinary Medicinal ProductsCritical 0 · Major 0 · Other 1
Paragraph
Critical
Major
Other
Total
Inspections
29
0
0
1
1
1
EU GMP Annex 6 Medicinal GasesCritical 0 · Major 2 · Other 22
Paragraph
Critical
Major
Other
Total
Inspections
5
0
1
1
2
2
9
0
0
2
2
2
30(a)
0
1
1
2
2
30(c)
0
0
2
2
2
7
0
0
1
1
1
8(a-b)
0
0
1
1
1
13
0
0
1
1
1
16
0
0
1
1
1
17(a-o)
0
0
1
1
1
22
0
0
1
1
1
26
0
0
1
1
1
27
0
0
1
1
1
30(f)
0
0
1
1
1
30(g)
0
0
1
1
1
31
0
0
1
1
1
35
0
0
1
1
1
36
0
0
1
1
1
38
0
0
1
1
1
40(a-d)
0
0
1
1
1
44
0
0
1
1
1
EU GMP Annex 8 Sampling of Starting and Packaging MaterialsCritical 0 · Major 11 · Other 75
Paragraph
Critical
Major
Other
Total
Inspections
4
0
6
40
46
45
5
0
3
22
25
25
2
0
1
6
7
7
3
0
0
5
5
5
Principle
0
1
1
2
2
1
0
0
1
1
1
EU GMP Annex 9 Liquids, Creams and OintmentsCritical 0 · Major 6 · Other 3
Paragraph
Critical
Major
Other
Total
Inspections
1
0
2
0
2
2
7
0
1
1
2
2
2
0
0
1
1
1
4
0
1
0
1
1
8
0
1
0
1
1
9
0
1
0
1
1
Principle
0
0
1
1
1
EU GMP Annex 10 Pressurised Metered Dose Aerosol Preparations for InhalationCritical 0 · Major 0 · Other 2
Paragraph
Critical
Major
Other
Total
Inspections
2
0
0
1
1
1
5
0
0
1
1
1
EU GMP Annex 11 Computerised SystemsCritical 10 · Major 134 · Other 295
Paragraph
Critical
Major
Other
Total
Inspections
1
0
17
35
52
52
7.2
1
14
29
44
43
12.1
1
12
29
42
42
9
1
7
22
30
30
11
0
6
23
29
28
Principle
0
6
20
26
25
2
0
7
12
19
19
6
1
8
10
19
19
7.1
1
4
13
18
18
4.3
0
5
12
17
17
10
0
4
13
17
17
4.7
0
4
10
14
14
12.4
2
5
6
13
13
5
1
3
8
12
12
12.2
0
2
8
10
10
4.1
0
6
3
9
9
12.3
0
2
6
8
8
3.1
0
1
6
7
7
4.8
0
2
5
7
7
17
0
3
3
6
6
4.4
0
3
2
5
5
4.2
0
0
4
4
4
4.5
0
2
2
4
4
8.1
0
2
2
4
4
12(1-4)
0
2
2
4
4
14(a-c)
0
2
2
4
4
4.6
0
0
3
3
3
8.2
2
0
1
3
3
3.2
0
1
1
2
2
3.3
0
1
1
2
2
7(1-2)
0
2
0
2
2
4(1-8)
0
1
0
1
1
13
0
0
1
1
1
16
0
0
1
1
1
EU GMP Annex 12 Use of Ionising RadiationCritical 0 · Major 3 · Other 3
Paragraph
Critical
Major
Other
Total
Inspections
1
0
1
1
2
2
4
0
1
1
2
2
3
0
1
0
1
1
12
0
0
1
1
1
EU GMP Annex 13 Investigational Medicinal ProductsCritical 0 · Major 46 · Other 56
Paragraph
Critical
Major
Other
Total
Inspections
40
0
3
8
11
11
9
0
3
7
10
9
24
0
2
5
7
7
13
0
3
2
5
5
38
0
3
2
5
5
12
0
2
2
4
4
41
0
1
3
4
4
43
0
0
4
4
4
49
0
1
3
4
4
Principle
0
3
1
4
4
11
0
2
1
3
3
21
0
3
0
3
3
39(a-d)
0
1
2
3
3
44
0
0
3
3
3
1
0
2
0
2
2
2
0
2
0
2
2
3
0
1
1
2
2
4
0
2
0
2
2
10
0
2
0
2
2
15
0
1
1
2
2
22
0
2
0
2
2
33
0
1
1
2
2
36
0
1
1
2
2
37
0
0
2
2
2
50
0
0
2
2
2
6
0
0
1
1
1
8
0
1
0
1
1
14
0
1
0
1
1
23
0
1
0
1
1
26(a-k)
0
1
0
1
1
26(j)
0
0
1
1
1
35
0
1
0
1
1
42
0
0
1
1
1
51
0
0
1
1
1
54
0
0
1
1
1
EU GMP Annex 14 Medicinal Products Derived from Human Blood or PlasmaCritical 0 · Major 0 · Other 1
Paragraph
Critical
Major
Other
Total
Inspections
4.2
0
0
1
1
1
EU GMP Annex 15 Qualification and ValidationCritical 17 · Major 472 · Other 594
Paragraph
Critical
Major
Other
Total
Inspections
4.1
0
14
31
45
42
2.9
0
13
31
44
42
11.4
0
23
21
44
42
1.7
0
18
20
38
37
2.8
0
10
27
37
35
2.4
0
12
24
36
32
4.2
0
6
25
31
31
5.7
0
12
18
30
29
10.5
2
18
9
29
29
Principle
0
15
14
29
26
10.6(1-2)
2
17
9
28
28
10.15
2
18
7
27
27
10.2
1
14
10
25
25
2.1
0
12
12
24
22
1.8
1
8
13
22
22
2.10
0
6
13
19
19
10.1
1
10
8
19
19
11.6
0
8
11
19
19
General
0
4
15
19
19
2.7
0
8
10
18
17
10.11
1
13
4
18
18
3.14(i-ii)
0
10
7
17
17
10.12
2
12
3
17
17
11.5
0
6
11
17
17
11.7
0
8
9
17
17
6.3
0
7
9
16
16
11.1
0
2
14
16
16
3.14(ii)
0
3
12
15
15
3.2
0
3
11
14
14
2.2
0
4
9
13
13
10.10
1
9
3
13
13
11.2
0
7
6
13
13
1.5(i-vii)
0
7
5
12
12
3.1
0
6
6
12
11
10.8
0
5
7
12
12
10.13
0
7
5
12
12
2.6
0
8
3
11
11
1.1
0
8
2
10
9
3.11(i-ii)
0
5
5
10
10
1.5(iii)
0
2
7
9
8
1.5(vii)
0
2
6
8
8
2.3
0
7
1
8
8
5.16
0
2
6
8
8
6.2
0
0
8
8
8
10.3
1
4
3
8
8
1.6
0
3
4
7
7
3.12
0
3
4
7
7
6.4
0
0
7
7
7
(whole chapter)
0
6
0
6
1
5.9
0
3
3
6
6
5.19
0
0
6
6
6
6.1
0
0
6
6
6
7.2
0
2
4
6
6
9.1
1
2
3
6
6
10.9
1
4
1
6
6
10.14
0
5
1
6
6
1.4
0
2
3
5
5
3.3
0
1
4
5
5
3.11(i)
0
3
2
5
5
3.13
0
4
1
5
5
3.14(i)
0
2
3
5
5
1.5(v)
0
0
4
4
4
1.5(vi)
0
1
3
4
4
3.11(ii)
0
2
2
4
4
5.3
0
2
2
4
4
8.1
0
2
2
4
4
9.2
0
0
4
4
4
1.2
0
0
3
3
3
3.8
0
2
1
3
3
3.9(i)
0
1
2
3
3
3.9(i-v)
0
1
2
3
3
5.1
0
1
2
3
3
5.14
0
2
1
3
3
5.30
0
1
2
3
3
5.31
0
2
1
3
3
7.1
0
3
0
3
3
8.2
0
1
2
3
3
10.4
1
2
0
3
3
3.9(ii)
0
2
0
2
2
5.5
0
2
0
2
2
5.21
0
1
1
2
2
5.22(i-xii)
0
1
1
2
2
5.29
0
1
1
2
2
8.3
0
0
2
2
2
9.3
0
1
1
2
2
10.6
0
1
1
2
2
10.7
0
2
0
2
2
1.3
0
1
0
1
1
1.5
0
0
1
1
1
1.5 (vii)
0
0
1
1
1
1.5(iv)
0
0
1
1
1
3.9(v)
0
0
1
1
1
3.10
0
1
0
1
1
5.2.2
0
0
1
1
1
5.8
0
0
1
1
1
5.12
0
0
1
1
1
5.18
0
0
1
1
1
5.20
0
0
1
1
1
5.22(vii)
0
0
1
1
1
5.28
0
0
1
1
1
5.32
0
0
1
1
1
10.6.1
0
1
0
1
1
10.6.2
0
1
0
1
1
11.3
0
1
0
1
1
EU GMP Annex 16 Certification by a Qualified Person and Batch ReleaseCritical 0 · Major 109 · Other 167
Paragraph
Critical
Major
Other
Total
Inspections
Principle
0
5
15
20
20
1.7.16
0
10
6
16
16
1.7.2
0
2
13
15
15
1.5.5
0
3
11
14
14
1.7(1-21)
0
5
8
13
13
1.7.3
0
5
7
12
11
1.3
0
3
8
11
11
1.5.6(i-iv)
0
3
7
10
10
1.6(iii)
0
5
5
10
10
1.10.1
0
1
8
9
9
1.5.4
0
5
3
8
8
1.7.5
0
3
4
7
7
1.7.21
0
1
6
7
7
1.4.3
0
2
4
6
6
1.7.10
0
2
4
6
6
3
0
3
3
6
6
1.2
0
4
1
5
5
1.7.6
0
2
3
5
5
1.7.15
0
3
2
5
5
1.7.17
0
2
3
5
5
2.1
0
2
3
5
5
1.5.3
0
3
1
4
4
1.7.1
0
2
2
4
4
1.7.13
0
3
1
4
4
2.2(iv)
0
3
1
4
4
1.4.1
0
1
2
3
3
1.5.6(iii)
0
1
2
3
3
1.7.14
0
3
0
3
3
2.2(vi)
0
3
0
3
2
4.1
0
1
2
3
3
4.2
0
1
2
3
3
1.5.6(ii)
0
1
1
2
2
1.5.6(iv)
0
1
1
2
2
1.6(i)
0
0
2
2
2
1.6(ii)
0
0
2
2
2
1.7.4
0
1
1
2
2
1.7.7
0
0
2
2
2
1.7.11
0
0
2
2
2
1.7.12
0
1
1
2
2
1.7.18
0
1
1
2
2
1.7.20
0
1
1
2
2
1.9.2
0
2
0
2
2
2.2(iii)
0
1
1
2
2
3.1(i)
0
1
1
2
2
(whole chapter)
0
1
0
1
1
1.1
0
0
1
1
1
1.4(1-3)
0
0
1
1
1
1.4.2
0
0
1
1
1
1.5.2
0
0
1
1
1
1.5.6(i)
0
1
0
1
1
1.5.7(ii)
0
0
1
1
1
1.5.7(iv)
0
1
0
1
1
1.5.7(v)
0
0
1
1
1
1.6
0
1
0
1
1
1.6(i-iii)
0
1
0
1
1
1.7.8
0
0
1
1
1
1.7.9
0
0
1
1
1
1.7.19
0
0
1
1
1
1.10(1-2)
0
0
1
1
1
2.2(i)
0
1
0
1
1
2.2(i-vi)
0
0
1
1
1
2.2(ii)
0
1
0
1
1
3.1(i-iii)
0
0
1
1
1
3.1(iii)
0
0
1
1
1
4.3
0
0
1
1
1
EU GMP Annex 17 Real Time Release Testing and Parametric ReleaseCritical 0 · Major 1 · Other 0
Paragraph
Critical
Major
Other
Total
Inspections
3.4
0
1
0
1
1
EU GMP Annex 19 Reference and Retention SamplesCritical 0 · Major 4 · Other 12
Paragraph
Critical
Major
Other
Total
Inspections
5.2
0
2
2
4
4
5.1
0
1
2
3
3
2.1
0
0
2
2
2
2.3
0
0
2
2
2
9.2
0
0
2
2
2
2.4
0
1
0
1
1
3.2
0
0
1
1
1
8.1
0
0
1
1
1
EU GMP Other or unreadableCritical 0 · Major 0 · Other 1
Paragraph
Critical
Major
Other
Total
Inspections
Chapter 10
0
0
1
1
1
Source and how to read
The data has no deficiency wording, only an anonymised inspection number, the grade (Critical, Major, Other) and the clause. A deficiency that cites several clauses is counted once per clause. Inspections is the number of inspections that cited that paragraph. 29 rows without a readable clause or grade are left out of the tables. As of 2026-11-10.
GRM counted the rows of the source data by clause and paragraph and arranged them into tables. It may differ from the original — always check the source file. This page was not made or reviewed by MHRA.
Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.